26Microglia, the resident immune cells of the brain parenchyma, are thought to be first-line defenders 27 against CNS infections. We sought to identify specific roles of microglia in the control of the 28 eukaryotic parasite Toxoplasma gondii, an opportunistic infection that can cause severe 29 neurological disease. In order to identify the specific function of microglia in the brain during 30 infection, we sorted microglia and infiltrating myeloid cells from infected microglia reporter mice. 31Using RNA-sequencing, we find strong NF-kB and inflammatory cytokine signatures 32 overrepresented in blood-derived macrophages versus microglia. Interestingly, we also find that 33 IL-1a is enriched in microglia and IL-1b in macrophages, which was also evident at the protein 34 level. We find that mice lacking IL-1R1 or IL-1a, but not IL-1b, have impaired parasite control 35 and immune cell infiltration specifically within the brain. Further, by sorting purified populations 36 from infected brains, we show that microglia, not peripheral myeloid cells, release IL-1a ex vivo. 37Finally, using knockout mice as well as chemical inhibition, we show that ex vivo IL-1a release is 38 gasdermin-D dependent, and that gasdermin-D and caspase-1/11 deficient mice show deficits in 39 immune infiltration into the brain and parasite control. These results demonstrate that microglia 40 and macrophages are differently equipped to propagate inflammation, and that in chronic T. gondii 41 infection, microglia specifically can release the alarmin IL-1a, a cytokine that promotes 42 neuroinflammation and parasite control. 43 44 45 46In this work, we have focused on IL-1, its expression by microglia and macrophages, as 70 well as its role in the brain during chronic T. gondii infection. IL-1 molecules include two main 71 cytokines: IL-1a and IL-1b. IL-1a can function as a canonical alarmin, which is a pre-stored 72 molecule that does not require processing and can be released upon cell death or damage, making 73 it an ideal candidate for an early initiator of inflammation. 19,20 In contrast, IL-1b is produced first 74 as a pro-form that requires cleavage by caspase-1 in order for it to be biologically active, rendering 75 IL-1b dependent on the inflammasome as a platform for caspase-1 activation. [21][22][23] Both of these 76 cytokines signal through the same receptor (IL-1R), a heterodimer of IL-1R1 and IL-1RAcP, with 77 similar affinity. 24 They also lack signal sequences and thus require a loss of membrane integrity to 78 be released. Caspase-mediate cleavage of gasdermin molecules has been identified as a major 79 pathway leading to pore formation and IL-1 release. 80The role of IL-1b and inflammasome pathways in T. gondii infection has been studied in 81 vitro as well as in rodent models of acute infection. In sum, these studies suggest roles for IL-1b, 82 IL18, IL-1R, NLRP1 and/or NLPR3 inflammasome sensors, the inflammasome adaptor protein 83 ASC, and inflammatory caspases-1 and -11. 25-28 However, the role of IL-1 signaling in the brain ...